RWE Alliance to boost policies and practices around real-world evidence

• “We are a coalition of real-world data and analytics organizations with a common interest in harnessing the power of real-world evidence to inform regulatory decision-making to improve patients’ lives” Company statement
• The goal is to engage with regulators and policymakers at the U.S. Food and Drug Administration and on Capitol Hill to help advocate for more advanced use of data derived from electronic health records, insurance claims, product and disease registries, connected devices, wearables, apps and other sources from outside of clinical trials
• The alliance will also work alongside patient groups, pharma companies, medical device manufacturers and other key stakeholders to support broader efforts around the use of RWE, which members say helps regulators, developers and providers have a deeper understanding of medical product safety and efficacy

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: MAY2021CW001